Re:Humira’s Drug Formula: Start at a High Price, Go Higher
by smashd on Monday January 08, 2018 @12:43PM
(#16098371)
It's not limited to AbbVie either, I get Xolair injections for chronic hives and Genentech uses a similar program. I assumed they were making a profit from the insurance-covered portion of the cost and used the program to maximize the number of people taking the drug. That idea in itself is pretty "clever" but if they also get to call the program-covered portion a "charitable contribution" then that is really something special.
[ Parent
| on HN ]
There are no comments on this comment yet.